<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Hereford Medical Group</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Hereford Medical Group is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0904010AY&amp;denomIds=9.4.1&amp;selectedTab=summary">Gluten free/low protein drink</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Foods for special diets</td>
      <td>385</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>14.44</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0904010AYBBAAAA&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia Lattis low protein drink : 8</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1404000N0&amp;denomIds=14.4&amp;selectedTab=summary">Rabies</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Vaccines and antisera</td>
      <td>33</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.26</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1404000N0BDABAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Rabipur vacc inj 1ml pre-filled syringes : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0403010T0&amp;denomIds=4.3.1&amp;selectedTab=summary">Mianserin hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Tricyclic and related antidepressant drugs</td>
      <td>6875</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>2.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0403010T0AAACAC&amp;denomIds=4.3.1&amp;selectedTab=summary" target="_blank">Mianserin 30mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0803042S0&amp;denomIds=8.3.4&amp;selectedTab=summary">Triptorelin embonate</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>49</td>
      <td>Prostate cancer and gonadorelin analogues</td>
      <td>230</td>
      <td>0.21</td>
      <td>0.02</td>
      <td>0.07</td>
      <td>2.53</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0803042S0BCAAAB&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Decapeptyl SR 22.5mg inj vials : 49</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0407020H0&amp;denomIds=4.7.2&amp;selectedTab=summary">Dipipanone hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Opioid analgesics</td>
      <td>8263</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>2.48</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0407020H0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Dipipanone 10mg / Cyclizine 30mg tablets : 10</a></div></td></tr></tbody></table>

        <h2>Prescribing where Hereford Medical Group is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000&amp;denomIds=13.2.1&amp;selectedTab=summary">Other emollient preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>689</td>
      <td>Emollients</td>
      <td>933</td>
      <td>0.74</td>
      <td>0.89</td>
      <td>0.07</td>
      <td>-2.15</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000AAA6A6&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">White soft paraffin 50% / Liquid paraffin 50% ointment : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBCJA8&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno cream : 40</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBICBW&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol 500 lotion : 318</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBJGCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase gel : 103</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBKFA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol cream : 62</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBKKCD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Oilatum Junior cream : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBJMCB&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno lotion : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBMFCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase emollient shower gel : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000AACACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Isopropyl myristate 15% / Liquid paraffin 15% gel : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBBAAL&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">E45 cream : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBJPCD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Oilatum cream : 17</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBLACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase Dayleve gel : 12</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBMGCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase emollient wash gel : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBAHAV&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Ultrabase cream : 25</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBAEA3&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Diprobase ointment : 20</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBKDA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno Skin Relief moisturising lotion with shea butter : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1501030G0&amp;denomIds=15.1.3&amp;selectedTab=summary">Glycopyrronium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Antimuscarinic drugs</td>
      <td>78</td>
      <td>0.08</td>
      <td>0.82</td>
      <td>0.36</td>
      <td>-2.08</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1501030G0AAAAAA&amp;denomIds=15.1.3&amp;selectedTab=summary" target="_blank">Glycopyrronium bromide 200micrograms/1ml inj ampoules : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1202010U0&amp;denomIds=12.2.1&amp;selectedTab=summary">Mometasone furoate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>237</td>
      <td>Drugs used in nasal allergy</td>
      <td>2079</td>
      <td>0.11</td>
      <td>0.31</td>
      <td>0.13</td>
      <td>-1.49</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1202010U0AAAAAA&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Mometasone 50micrograms/dose nasal spray : 224</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1202010U0BBAAAA&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Nasonex 50micrograms/dose nasal spray : 13</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>579</td>
      <td>Aminosalicylates</td>
      <td>1353</td>
      <td>0.43</td>
      <td>0.64</td>
      <td>0.15</td>
      <td>-1.45</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BBAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 400mg MR gastro-resistant tablets : 60</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BBAFAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 800mg MR gastro-resistant tablets : 95</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 58</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAFAT&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 2g modified-release granules sachets : 31</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAGAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release tablets : 112</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAKAZ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 3g gastro-resistant modified-release gran sachets : 77</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDACAB&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg suppositories : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAAAC&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa Mesalazine 1g/100ml enema : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAGAP&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg gast res MR gran sachets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCADAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g suppositories : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAANAN&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g modified-release granules sachets sugar free : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAEAN&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release granules sachets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAHAU&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1.5g gastro-resistant modified-release gran sachets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAWAW&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg gastro-resistant tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAYAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g modified-release tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAHBA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 4g modified-release granules sachets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDADAL&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 2g/59ml enema : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BHAAAR&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mezavant XL 1200mg tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 12</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAEAK&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g/application foam enema : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 400mg gastro-resistant tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAPAP&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg gast res MR gran sachets sugar free : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAJAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g suppositories : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BIABAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 400mg MR gastro-resistant tablets : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAIAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg modified-release tablets : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAIAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g suppositories : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0803041L0&amp;denomIds=8.3.4&amp;selectedTab=summary">Letrozole</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>110</td>
      <td>Breast cancer</td>
      <td>865</td>
      <td>0.13</td>
      <td>0.44</td>
      <td>0.22</td>
      <td>-1.45</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0803041L0AAAAAA&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Letrozole 2.5mg tablets : 110</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>